The goal of any MPD treatment is to safeguard your health both in the short and the long term.
If you have a mild MPD, low-dose aspirin (together with phlebotomy for those with PV) may reduce your risks of clotting. If your MPD is more active, your haematologist can recommend treatments to reduce your blood cell production. If you have MF, you may be given some of the same treatments used in ET and PV to reduce blood cells production, along with additional drugs.
Download leaflets about hydroxycarbamide, anagrelide, interferon, aspirin and travel.
Anagrelide slows the production of blood cells. In Europe it is recommended as a second line treatment.
Integrative medicine optimizes your wellbeing by looking at health from many different perspectives.
Familiar old aspirin has been demonstrated to reduce the risk of heart attack and stroke.
If you have PV phlebotomy can reduce your red cell counts by taking out some blood: advice and tips here.
Hydroxycarbamide is one of the most frequently prescribed drugs used to treat MPDs.
Interferons are substances which occur naturally in our bodies and which fight infections.
Thalidomide can reduce anaemia and possibly reverse some fibrous deposits in people with myelofibrosis.
Cytarabine can be used to treat myelofibrosis. It interferes with cell production.
These drugs were the main therapies used to treat ET in the past, and are still used in certain situations.
Bone marrow transplants can be an option for some people with myelofibrosis.
Additional treatments may be given for myelofibrosis or to control common problems.